In uno omnia: Anti-thrombotic agents in challenging comorbidities

References

• Engelhardt K, Brenneis C, Pfausler B, Beer R, Brössner G, Helbok R, Lackner P, Schmutzhard E. rFVIIa for acute rebleeding of a cerebral cavernous malformation. European Journal of Neurology 2007; 14: 117–120
   PubMed Web of Science ®Google Scholar
• Verlaan DJ, Laurent SB, Sure U, Bertalanffy H, Andermann E, Andermann F, Rouleau GA, Siegel AM. CCM1 mutation screen of sporadic cases with cerebral cavernous malformations. Neurology 2004; 62: 1213–1215
   PubMed Web of Science ®Google Scholar
• Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA, on behalf of the Angioma Alliance Scientific Advisory Board. Hemorrhage from cavernous malformations of the brain. Definition and reporting standards. Stroke 2008; 39: 3222–3230
   PubMed Web of Science ®Google Scholar
• Juvela S, Kase CS. Advances in intracerebral hemorrhage management. Stroke 2006; 37: 301–304
   PubMedGoogle Scholar
• Stapf C, Hervé D. From cavern-dwellers to cavernoma science. Towards a new philosophy of cerebral cavernous malformations. Stroke 2008; 39: 3129–3130
   PubMed Web of Science ®Google Scholar
• Donnan GA, Ly J. Aspirin after intracerebral haemorrhage: Probably safer than we thought. Lancet Neurology 2006; 5: 288–289
   PubMed Web of Science ®Google Scholar
• Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: Case-control study. British Medical Journal 1999; 318: 759–764
   PubMedGoogle Scholar
• Dickmann U, Voth E, Schicha H, Henze T, Prange H, Emrich D. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klinishe Wochenschrift 1988; 66: 1182–1183
   PubMedGoogle Scholar
• Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. Journal of Neurology, Neurosurgery and Psychiatry 1991; 54: 466–467
   PubMed Web of Science ®Google Scholar
• Viswanathan A, Rakich SM, Engel C, Snider R, Rosand J, Greenberg SM, Smith EE. Antiplatelet use after intracerebral hemorrhage. Neurology 2006; 66: 206–209
   PubMed Web of Science ®Google Scholar
• Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995; 26: 1471–1477
   Google Scholar
• Toyoda K, Okada Y, Minematsu K, Kamouchi M, Fujimoto S, Ibayashi S, Inoue T. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 2005; 65: 1000–1004
   PubMed Web of Science ®Google Scholar
• Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen ER, Hillbom M. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 2006; 37: 129–133
   PubMed Web of Science ®Google Scholar
• Hanger HC, Fletcher VJ, Wilkinson TJ, Brown AJ, Frampton CM, Sainsbury R. Effect of aspirin and warfarin on early survival after intracerebral haemorrhage. Journal of Neurology 2008; 255: 347–352
   PubMed Web of Science ®Google Scholar
• Théroux P, Fuster V. Acute coronary syndromes: Unstable angina and non-Q-wave myocardial infarction. Circulation 1998; 97: 1195–1206
   PubMed Web of Science ®Google Scholar
• Théroux P, Ouimet H, McCans J, Latour JG, Joly P, Lévy G, Pelletier E, Juneau M, Stasiak J, deGuise P, et al. Aspirin, heparin, or both to treat acute unstable angina. New England Journal of Medicine 1988; 319: 1105–1111
   PubMed Web of Science ®Google Scholar
• The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827–830
   PubMed Web of Science ®Google Scholar
• Lewis HD, Jr, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, 3rd, Schnaper HW, LeWinter MM, Linares E, Pouget JM, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. New England Journal of Medicine 1983; 309: 396–403
   PubMed Web of Science ®Google Scholar
• Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG, et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. New England Journal of Medicine 1985; 313: 1369–1375
   PubMed Web of Science ®Google Scholar
• Balsano F, Rizzon P, Violi F, Scrutinio D, Cimminiello C, Aguglia F, Pasotti C, Rudelli G. Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell’Angina Instabile Group. Circulation 1990; 82: 17–26
   PubMed Web of Science ®Google Scholar
• The CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–1339
   PubMed Web of Science ®Google Scholar
• Théroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. New England Journal of Medicine 1992; 327: 141–145
   PubMed Web of Science ®Google Scholar